Literature DB >> 26807180

Factor Xa induces pro-inflammatory cytokine expression in RAW 264.7 macrophages via protease-activated receptor-2 activation.

Pengfei Zuo1, Zhi Zuo1, Xin Wang1, Long Chen1, Yueyue Zheng1, Genshan Ma1, Qianxing Zhou1.   

Abstract

Coagulation proteases have been suggested to trigger a diversity of inflammatory responses in addition to their critical role in the coagulation cascade. It has been well established that the inflammatory and coagulation pathways are invariably linked. However, the mechanisms through which coagulation protease factor Xa (FXa) causes inflammation remain unclear. Thus, we assessed the pro-inflammatory effects of FXa in RAW 264.7 macrophages. We show that FXa elicits signal transduction in RAW 264.7 macrophages. FXa-induced signal transduction was dependent on the activation of protease-activated receptor 2 (PAR-2), PAR-2 desensitization but not PAR-1 desensitization abolished FXa-induced ERK1/2 phosphorylation. The PAR-2-dependent cellular effects of FXa led to the expression of pro-inflammatory cytokines IL-6, IL-8, TNF-α and IFN-γ in RAW 264.7 macrophages. Furthermore, a specific inhibitor of the ERK1/2 pathway, U0126, decreased the FXa-induced pro-inflammatory cytokines expression significantly. Taken together, our data indicate that FXa induces PAR-2-dependent pro-inflammatory activity in RAW 264.7 macrophages through the ERK1/2 pathway.

Entities:  

Keywords:  ERK1/2 pathway; Factor Xa; inflammation; protease-activated receptor 2

Year:  2015        PMID: 26807180      PMCID: PMC4697712     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  33 in total

1.  Anti-inflammatory activity of Angelica dahurica ethanolic extract on RAW264.7 cells via upregulation of heme oxygenase-1.

Authors:  Mee-Young Lee; Jin-Ah Lee; Chang-Seob Seo; Heykyung Ha; Hoyoung Lee; Jong-Keun Son; Hyeun-Kyoo Shin
Journal:  Food Chem Toxicol       Date:  2011-01-25       Impact factor: 6.023

Review 2.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

Review 3.  Signal integration between IFNgamma and TLR signalling pathways in macrophages.

Authors:  Kate Schroder; Matthew J Sweet; David A Hume
Journal:  Immunobiology       Date:  2006-07-05       Impact factor: 3.144

4.  FXa-induced responses in vascular wall cells are PAR-mediated and inhibited by ZK-807834.

Authors:  K McLean; S Schirm; A Johns; J Morser; D R Light
Journal:  Thromb Res       Date:  2001-08-15       Impact factor: 3.944

Review 5.  Tissue factor-factor VIIa signaling.

Authors:  L Vijaya Mohan Rao; Usha R Pendurthi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-11-29       Impact factor: 8.311

6.  Coagulation factor Xa induces an inflammatory signalling by activation of protease-activated receptors in human atrial tissue.

Authors:  Alicja Bukowska; Ines Zacharias; Sönke Weinert; Kerstin Skopp; Christian Hartmann; Christof Huth; Andreas Goette
Journal:  Eur J Pharmacol       Date:  2013-09-13       Impact factor: 4.432

7.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

Review 8.  Pulmonary fibrosis: cytokines in the balance.

Authors:  R K Coker; G J Laurent
Journal:  Eur Respir J       Date:  1998-06       Impact factor: 16.671

9.  Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Farshid Noorbakhsh; Shigeki Tsutsui; Nathalie Vergnolle; Leonie A Boven; Neda Shariat; Mohammed Vodjgani; Kenneth G Warren; Patricia Andrade-Gordon; Morley D Hollenberg; Christopher Power
Journal:  J Exp Med       Date:  2006-02-13       Impact factor: 14.307

10.  Factor Xa and thrombin, but not factor VIIa, elicit specific cellular responses in dermal fibroblasts.

Authors:  E B Bachli; C M Pech; K M Johnson; D J D Johnson; E G D Tuddenham; J H McVey
Journal:  J Thromb Haemost       Date:  2003-09       Impact factor: 5.824

View more
  10 in total

1.  FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms.

Authors:  Guillermo Moñux; Jose J Zamorano-León; Pablo Marqués; Bernardo Sopeña; J M García-García; G Laich de Koller; Bibiana Calvo-Rico; Miguel A García-Fernandez; J Serrano; Antonio López-Farré
Journal:  Br J Clin Pharmacol       Date:  2017-08-27       Impact factor: 4.335

2.  Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance.

Authors:  Devram S Ghorpade; Lale Ozcan; Ze Zheng; Sarah M Nicoloro; Yuefei Shen; Emily Chen; Matthias Blüher; Michael P Czech; Ira Tabas
Journal:  Nature       Date:  2018-03-21       Impact factor: 49.962

3.  Myeloid cell-derived coagulation tissue factor is associated with renal tubular damage in mice fed an adenine diet.

Authors:  Shu Yamakage; Yuji Oe; Emiko Sato; Koji Okamoto; Akiyo Sekimoto; Satoshi Kumakura; Hiroshi Sato; Mai Yoshida; Tasuku Nagasawa; Mariko Miyazaki; Sadayoshi Ito; Nigel Mackman; Nobuyuki Takahashi
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

4.  Protease-Activated Receptor-2 Deficiency Attenuates Atherosclerotic Lesion Progression and Instability in Apolipoprotein E-Deficient Mice.

Authors:  Pengfei Zuo; Zhi Zuo; Yueyue Zheng; Xin Wang; Qianxing Zhou; Long Chen; Genshan Ma
Journal:  Front Pharmacol       Date:  2017-09-14       Impact factor: 5.810

5.  Protective effect of rivaroxaban on arteriosclerosis obliterans in rats through modulation of the toll-like receptor 4/NF-κB signaling pathway.

Authors:  Xinjiang Lou; Zhi Yu; Xiaoxia Yang; Jie Chen
Journal:  Exp Ther Med       Date:  2019-07-03       Impact factor: 2.447

Review 6.  Recent advance in treatment of atherosclerosis: Key targets and plaque-positioned delivery strategies.

Authors:  Li Li; Sainan Liu; Jianying Tan; Lai Wei; Dimeng Wu; Shuai Gao; Yajun Weng; Junying Chen
Journal:  J Tissue Eng       Date:  2022-03-24       Impact factor: 7.813

Review 7.  Effects of Thrombin on the Neurovascular Unit in Cerebral Ischemia.

Authors:  Hui Cao; Sai Wang Seto; Deep Jyoti Bhuyan; Hoi Huen Chan; Wenting Song
Journal:  Cell Mol Neurobiol       Date:  2021-01-03       Impact factor: 5.046

8.  Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic mice.

Authors:  Phuong Tran Pham; Daiju Fukuda; Shusuke Yagi; Kenya Kusunose; Hirotsugu Yamada; Takeshi Soeki; Michio Shimabukuro; Masataka Sata
Journal:  Sci Rep       Date:  2019-08-01       Impact factor: 4.379

9.  Correlating Fibrinogen Consumption and Profiles of Inflammatory Molecules in Human Envenomation's by Bothrops atrox in the Brazilian Amazon.

Authors:  Irmgardt Alicia María Wellmann; Hiochelson Najibe Santos Ibiapina; Jacqueline Almeida Gonçalves Sachett; Marco Aurélio Sartim; Iran Mendonça Silva; Sâmella Silva Oliveira; Andréa Monteiro Tarragô; Ana Maria Moura-da-Silva; Marcus Vinícius Guimarães Lacerda; Luiz Carlos de Lima Ferreira; Adriana Malheiro; Wuelton Marcelo Monteiro; Allyson Guimarães Costa
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

Review 10.  Potential Therapeutic Roles for Direct Factor Xa Inhibitors in Coronavirus Infections.

Authors:  Rami A Al-Horani
Journal:  Am J Cardiovasc Drugs       Date:  2020-12       Impact factor: 3.283

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.